NDAORALSOLUTION
Approved
Mar 1988
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
4/8 — Partial
IMODIUM A-D (loperamide hydrochloride) by Johnson & Johnson is mechanism of action in vitro and animal studies show that loperamide hydrochloride capsules act by slowing intestinal motility and by affecting water and electrolyte movement through the bowel. First approved in 1988.
Drug data last refreshed 3h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IMODIUM A-D is an oral solution containing loperamide hydrochloride, a small-molecule antidiarrheal agent approved in 1988. It works by binding to opiate receptors in the gut wall to inhibit acetylcholine and prostaglandin release, reducing intestinal motility and increasing anal sphincter tone. The drug is indicated for symptomatic relief of acute diarrhea and is available over-the-counter.
LOE Approaching
As a mature, approaching LOE product with moderate competitive pressure (30/100), the brand team likely focuses on lifecycle management and defensive positioning rather than growth expansion.
Mechanism of Action
Mechanism of Action In vitro and animal studies show that loperamide hydrochloride capsules act by slowing intestinal motility and by affecting water and electrolyte movement through the bowel. Loperamide binds to the opiate receptor in the gut wall. Consequently, it inhibits the release of…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy Volunteers
Started Dec 2019
48 enrolled
Healthy
Efficacy and Safety Study of Loperamide Hydrochloride/Simethicone Chewable Tablet in Treatment of Acute Diarrhea With Abdominal Discomfort and Flatulence
Started Jul 2005
217 enrolled
Diarrhea
Career Relevance
Working on IMODIUM A-D offers experience in defensive brand management, generic competition strategy, and OTC marketing within a mature portfolio at Johnson & Johnson. This role is best suited for professionals seeking expertise in lifecycle extension, pricing pressure mitigation, and transition planning rather than launch excitement or clinical expansion.
Worked on IMODIUM A-D at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.